NEW YORK (360Dx) – The share prices of diagnostic firms continued an upward trajectory in May as the 360Dx Index climbed 7 percent in May compared to April.

After a sluggish start to 2018, May was the second month in a row with healthy growth for the index, following a 3 percent month-over-month improvement in April.

In total, 20 companies' share prices rose last month, paced by Invitae (+34 percent), Luminex (+33 percent), and Foundation Medicine (+30 percent). Five companies' stocks slipped in value, with Accelerate Diagnostics (-8 percent) the biggest decliner.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.